DD295158A5 - Verfahren zur herstellung von stereoisomeren der verbindung 4-[3-[ethyl-[3-(propylsulfinyl)-propyl]-amino]-2-hydroxypropoxy]-benzonitril - Google Patents

Verfahren zur herstellung von stereoisomeren der verbindung 4-[3-[ethyl-[3-(propylsulfinyl)-propyl]-amino]-2-hydroxypropoxy]-benzonitril Download PDF

Info

Publication number
DD295158A5
DD295158A5 DD90341730A DD34173090A DD295158A5 DD 295158 A5 DD295158 A5 DD 295158A5 DD 90341730 A DD90341730 A DD 90341730A DD 34173090 A DD34173090 A DD 34173090A DD 295158 A5 DD295158 A5 DD 295158A5
Authority
DD
German Democratic Republic
Prior art keywords
ethyl
benzonitrile
propyl
propylsulfinyl
hydroxypropoxy
Prior art date
Application number
DD90341730A
Other languages
German (de)
English (en)
Inventor
Knut O S Almgren
Kiell H Andersson
Bernt G D Duker
Bo R Lamm
Gert Ch Strandlund
Original Assignee
�����@������������������k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by �����@������������������k�� filed Critical �����@������������������k��
Publication of DD295158A5 publication Critical patent/DD295158A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/26Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/28Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/795Polymers containing sulfur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Graft Or Block Polymers (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
DD90341730A 1989-06-20 1990-06-16 Verfahren zur herstellung von stereoisomeren der verbindung 4-[3-[ethyl-[3-(propylsulfinyl)-propyl]-amino]-2-hydroxypropoxy]-benzonitril DD295158A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8902236A SE8902236D0 (sv) 1989-06-20 1989-06-20 Novel polystyrenesulfonate

Publications (1)

Publication Number Publication Date
DD295158A5 true DD295158A5 (de) 1991-10-24

Family

ID=20376341

Family Applications (1)

Application Number Title Priority Date Filing Date
DD90341730A DD295158A5 (de) 1989-06-20 1990-06-16 Verfahren zur herstellung von stereoisomeren der verbindung 4-[3-[ethyl-[3-(propylsulfinyl)-propyl]-amino]-2-hydroxypropoxy]-benzonitril

Country Status (29)

Country Link
US (1) US5068272A (pl)
EP (1) EP0404747B1 (pl)
JP (1) JPH04506213A (pl)
KR (1) KR920702675A (pl)
CN (1) CN1048220A (pl)
AT (1) ATE88463T1 (pl)
AU (1) AU641671B2 (pl)
BG (1) BG51351A3 (pl)
CA (1) CA2059282A1 (pl)
DD (1) DD295158A5 (pl)
DE (1) DE69001397T2 (pl)
DK (1) DK0404747T3 (pl)
ES (1) ES2054324T3 (pl)
FI (1) FI915936A7 (pl)
HR (1) HRP920600A2 (pl)
HU (1) HUT59086A (pl)
IE (1) IE902160A1 (pl)
IL (1) IL94676A0 (pl)
LT (1) LTIP1724A (pl)
MX (1) MX21203A (pl)
NO (1) NO914928L (pl)
NZ (1) NZ234022A (pl)
PL (1) PL163537B1 (pl)
PT (1) PT94416A (pl)
RU (1) RU2004539C1 (pl)
SE (1) SE8902236D0 (pl)
WO (1) WO1990015793A1 (pl)
YU (1) YU120590A (pl)
ZA (1) ZA904412B (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8705150D0 (sv) * 1987-12-23 1987-12-23 Haessle Ab Novel antiarrhythmic agents
SE8902235D0 (sv) * 1989-06-20 1989-06-20 Haessle Ab Novel cyclodextrin inclusion complexes
SE9003902D0 (sv) * 1990-12-07 1990-12-07 Astra Ab Solid dosage forms of a drug
US6290946B1 (en) 1999-05-13 2001-09-18 Geltex Pharmaceuticals, Inc. Anionic polymers as toxin binders and antibacterial agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1457876A (en) * 1972-12-15 1976-12-08 Ici Ltd Alkanolamine derivatives device for use in
GB1433920A (en) * 1973-10-01 1976-04-28 Ici Ltd Alkanolamine derivatives
SE8705150D0 (sv) * 1987-12-23 1987-12-23 Haessle Ab Novel antiarrhythmic agents
SE8902235D0 (sv) * 1989-06-20 1989-06-20 Haessle Ab Novel cyclodextrin inclusion complexes
SE8902237D0 (sv) * 1989-06-20 1989-06-20 Haessle Ab Novel stereoisomers

Also Published As

Publication number Publication date
NO914928D0 (no) 1991-12-13
YU120590A (sh) 1992-07-20
HRP920600A2 (en) 1994-08-31
HUT59086A (en) 1992-04-28
DE69001397T2 (de) 1994-03-17
CA2059282A1 (en) 1990-12-21
LTIP1724A (en) 1995-07-25
CN1048220A (zh) 1991-01-02
NZ234022A (en) 1992-05-26
PT94416A (pt) 1991-02-08
IL94676A0 (en) 1991-04-15
EP0404747B1 (en) 1993-04-21
WO1990015793A1 (en) 1990-12-27
JPH04506213A (ja) 1992-10-29
US5068272A (en) 1991-11-26
SE8902236D0 (sv) 1989-06-20
PL163537B1 (pl) 1994-04-29
IE902160A1 (en) 1991-01-02
IE902160L (en) 1990-12-20
HU905546D0 (en) 1992-03-30
FI915936A0 (fi) 1991-12-17
BG51351A3 (bg) 1993-04-15
AU5937790A (en) 1991-01-08
ES2054324T3 (es) 1994-08-01
FI915936A7 (fi) 1991-12-17
AU641671B2 (en) 1993-09-30
EP0404747A1 (en) 1990-12-27
ATE88463T1 (de) 1993-05-15
DE69001397D1 (de) 1993-05-27
NO914928L (no) 1991-12-13
DK0404747T3 (da) 1993-08-23
RU2004539C1 (ru) 1993-12-15
ZA904412B (en) 1991-02-27
KR920702675A (ko) 1992-10-06
MX21203A (es) 1993-11-01
PL285700A1 (en) 1991-02-11

Similar Documents

Publication Publication Date Title
DE3688827T2 (de) Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel.
EP0026848B1 (de) Tetralinderivate, ihre Herstellung und Heilmittel, welche diese Verbindungen enthalten
DE69210141T2 (de) Herstellung von Fluoxetin und Zwischenverbindungen
DD148052A5 (de) Verfahren zur herstellung neuer zwischenprodukte von arzneimitteln
DE69408580T2 (de) 2-amino-1,2,3,4-tetrahydronaphthalenderivate mit cardiovaskulärer wirkung
DE1670200A1 (de) Neue arylsubstituierte Piperazinylcarbonsaeureanilide und Verfahren zu deren Herstellung
DE2065312C3 (de) Aminoäthansulfonylderivate und Verfahren zu ihrer Herstellung
AT391866B (de) Verfahren zur herstellung neuer s-triazolo (1,5-a) pyrimidine
DD295158A5 (de) Verfahren zur herstellung von stereoisomeren der verbindung 4-[3-[ethyl-[3-(propylsulfinyl)-propyl]-amino]-2-hydroxypropoxy]-benzonitril
DE2000030C3 (de) 3-Alkoxy-und 3-Phenoxy-2-(diphenylhydroxy)methyl-propylamine und diese enthaltende Arzneimittel
DD140041B1 (de) Verfahren zur herstellung von langkettigen n-alkyldimethylmorpholinen
DE69001461T2 (de) Stereoisomere.
DE2704690C2 (de) Triphenylalkenderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE940827C (de) Verfahren zur Herstellung von organischen Arsenverbindungen
DD297404A5 (de) Verfahren zur herstellung eines salzes der verbindung 4-[3-[ethyl-(3-(propylsulfinyl)-propyl]-amino)-2-hydroxy-propoxy]-benzonitril
DD273250A5 (de) Verfahren zur herstellung von alpha-(1-methylethyl)-3,4-dimethoxybenzolacetonitril
DE1620128A1 (de) Verfahren zur Herstellung von neuen organischen Amiden
DE3216986A1 (de) 2-methoxyphenyl ester von n-substituierten aminosaeuren, verfahren fuer deren herstellung und pharmazeutische diese enthaltenden verbindungen
AT238181B (de) Verfahren zur Herstellung neuer Pyrrolidinverbindungen
DE1900948C (de) Cis- und trans-2-Methyl-5-(3, 4, S-trimethoxybenzamidoJ-decahydroisochinolin
DE2822473A1 (de) Alkanolaminderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
DE2901334A1 (de) Neue harnstoffderivate
DE1258416B (de) Verfahren zur Herstellung von L-alpha-Methyl-beta-(3, 4-dihydroxyphenyl)-alanin
AT364836B (de) Verfahren zur herstellung von neuen o-substituierten derivaten des (+)-cyanidan-3-ols und deren salzen
DE2414794C3 (de) Verfahren zur Herstellung von optisch aktivem Allethrolon

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee